Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
(NASDAQ: SNOA) Delayed: 1.25 -0.03 (2.34%)
Previous Close $1.28    52 Week High $ 
Open $1.28    52 Week Low $ 
Day High $1.28    P/E N/A 
Day Low $1.25    EPS $ 
Volume 27,582